Jemperli Could Let Some Rectal Cancer Patients Skip Chemotherapy, Radiation And Surgery
TUESDAY, Oct. 20, 2026 — Some people with rectal cancer may now be able to skip chemotherapy, radiation and surgery. The U.S. Food and Drug Administration (FDA) on Monday approved the immunotherapy Jemperli (dostarlimab-gxly) for certain...
.jpg%3Fwidth%3D1200)